The global Medical Nutrition Market is anticipated to be driven by rising incidences of malnutrition brought on by the quick spread of chronic diseases. One of the main causes of disability is chronic obstructive pulmonary disease (COPD). According to the World Health Organization (WHO), COPD is one of the leading causes of death globally, and the incidence is predicted to rise daily. Three million individuals are predicted to die worldwide from COPD in 2015. One of the frequent issues among COPD patients who need nutritional support for life is malnutrition.
Request for Free Sample Copy@ https://www.persistencemarketresearch.com/samples/16588
Parenteral nutrition use has increased during the past few years as a result of the load of the ageing population on the nutritional balance. The geriatric population’s increasing usage of home parenteral nutrition therapy for conditions like diabetes, cancer, and AIDS is predicted to fuel the expansion of the worldwide medical nutrition market.
Leading businesses creating novel parenteral nutrition medications are seeing unheard-of growth in their R&D pipelines as a result of rising spending. Companies that operate in the worldwide medical nutrition market work to provide cutting-edge or conventional nutritional solutions that reliably and adequately satisfy the dietary needs of patients under various clinical circumstances. In the recent years, a number of businesses have been successful in obtaining regulatory approval for brand-new, potent parenteral feeding medications.
Get up to 20% discount on Full Report Purchase @ https://www.persistencemarketresearch.com/checkout/16588
The global parenterally administered medical nutrition market is anticipated to grow from over US$ 3,200 Mn in 2016 to more than US$ 6,000 Mn by 2025 end. This represents a CAGR of 7.2% in terms of value over the forecast period. The global parenterally administered medical nutrition market represents incremental opportunity of more than US$ 2,500 Mn between 2017 and 2025.
North America dominated global parenteral medical nutrition market in terms of revenue in 2016, and the market trend is projected to grow throughout the forecast period. North America segment is the most attractive regional market, with attractiveness index of 2.2 over the forecast period. Revenue from the North America market is anticipated to increase at a CAGR of 8.7% over 2017–2025, to reach a market valuation in excess of US$ 2,300 Mn by 2025.
Request For Customization @ https://www.persistencemarketresearch.com/request-customization/16588
Companies Covered in This Report – Advanced Medical Nutrition Market
-
- Allergan
- Baxter International Inc.
- Braun Melsungen AG.
- Fresenius Kabi AG
- Pfizer, Inc.
- Sanofi
- Mead Johnson & Company, LLC
- Sichuan Kelun Pharmaceutical Company Limited
- Otsuka Pharmaceuticals Co., Ltd.
- Grifols S.A.
- Abbott Laboratories
- Danone Nutricia
- Demo S.A. Pharmaceutical Industry
Related Reports:
About Us:
Persistence Market Research’s Expertise in Life Sciences and Transformational Health
Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations. Click here to learn more about how we zero in on the critical aspects of this industry.
Contact Us:
Persistence market research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]